4Yee D,Valiquette C, Pelletier M, Parisien 1,Rocher I, Menzies D. Incidence of serious side effects form first line antituberculo sis drugs among treated for active tuberculosis[J].Am J Rrespir Crite Med, 2003,167(11) : 1472-- 1477.
5Goyal J L,De S,Singh N P,Bhatia A. Evaluation of visual function in patients on etlaambutal therapy for tuberculosis: a prospective study [J]. J Commun Dis,2003,35(4):230--243.
7Choi SY, Hwang JM. Optic neuropathy associated with etham butaI in Koreans [J]. Korean J Ophthalmol,1997,11(2) :106-- 111.
8Ali S, Usman U, Wasay M. Rapidly developing optic neuritis Secondary to ethambutol:Possi ble Mechanism of injury[J]. J Pak Med Assoc,2005,55(7) :300--302.
9Sivakumaran P, Harrison A C,Marschner J, Mart NP. Ocular toxicity form ethambutol:a review of four cases and recommended precautions [J]. N Z Med J,1999,112(1082) :57-58.
10Kozak SF, Inderlied CB, Hsu, HY, Heller KB,Sadun AA. The role of copper on ethambutol's antimicrobial action and implications for ethambutal-induced optic neuropathy [J]. Diagn Micobiol Infect Dis,1998,30(2):83--87.
5Sharp P M,Hahn B H. Origins of HIV and the AIDS Pandemic[J].Cold Spring Harb Perspect Med,2011,(01):a006841.
6尤黎明.内科护理学[M]北京:人民卫生出版社,200642.
7Liachopoulou A P,Synodinou-Kamilou E E,Deligiannidi P G. Nurses' training and confidence on deep venous catheterization[J].Technology and Health Care,2008,(03):159.
8Garg R K,Sinha M K. Tuberculous meningitis in patients infected with human immunodeficiency virus[J].Journal of Neurology,2011,(01):3.
9Marais S,Pepper D J,Marais B J. HIV-associated tuberculous meningitis--diagnostic and therapeutic challenges[J].Tuberculosis(Edinb),2010,(06):367.
